Overall rank by patents
#3,269
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
UTI Inc.
USPTO PatentsView assignee record - 115 granted patents across 95 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
115
Total patents granted
95
CPC technology areas
17.0
Avg claims per patent
+148%
5-year filing velocity
The verdict
UTI holds 115 US patents across 95 technology areas, rank #3,269 of 50,000 tracked assignees.
- #3,269
- of 50,000 US assignees by volume
- Top 2%
- by Innovation Score (63.0/100)
- 17.0
- avg claims per patent
- +148%
- filing velocity, last 5 yrs
Portfolio overview
UTI Inc. has been granted 115 US utility patents between 2015 and 2025, placing UTI Inc. at rank #3,269 across all assignees tracked by PlainPatent. This portfolio spans 95 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, UTI Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, UTI sits between Shofu Inc. (115 patents, rank #3,265) and Bard Peripheral Vascular, Inc. (114 patents, rank #3,273) - the closest US assignees by grant volume. The composite Innovation Score of 63.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 82 grants, compared with 33 in the 2015–2019 window, a +148% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. UTI Inc.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 95 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark UTI Inc. against peers pursuing similar technology classes.
Who files at UTI's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Shofu
SHOFU INC.
115 patents
- Simpson Strong-tie
Simpson Strong-Tie Company, Inc.
115 patents
- Singular Genomics…
Singular Genomics Systems, Inc.
115 patents
- Tmeic
TMEIC CORPORATION
115 patents
- UTI ◀
UTI INC.
115 patents
- Abbyy Development
ABBYY Development Inc.
114 patents
- Asana
Asana, Inc.
114 patents
- Baidu COM Times T…
BAIDU.COM TIMES TECHNOLOGY (BEIJING) CO., LTD.
114 patents
- Bard Peripheral V…
Bard Peripheral Vascular, Inc.
114 patents
What this shows UTI holds 115 patents at rank #3,269, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near UTI
By rank, the assignees closest to #3,269 in granted patent volume.
- Shofu Inc. #3,265 · 115 patents
- Simpson Strong-tie Company, Inc. #3,266 · 115 patents
- Singular Genomics Systems, Inc. #3,267 · 115 patents
- Tmeic Corporation #3,268 · 115 patents
- Abbyy Development Inc. #3,270 · 114 patents
- Asana, Inc. #3,271 · 114 patents
- Baidu.com Times Technology (beijing) Co., Ltd. #3,272 · 114 patents
- Bard Peripheral Vascular, Inc. #3,273 · 114 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in UTI's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
UTI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 3.5% |
| 2016 | 4 | 3.5% |
| 2017 | 7 | 6.1% |
| 2018 | 8 | 7.0% |
| 2019 | 10 | 8.7% |
| 2020 | 9 | 7.8% |
| 2021 | 12 | 10.4% |
| 2022 | 15 | 13.0% |
| 2023 | 20 | 17.4% |
| 2024 | 18 | 15.7% |
| 2025 | 8 | 7.0% |
Which technologies does UTI Inc. patent most?
Top 15 of 95 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does UTI Inc. hold?
UTI Inc. holds 115 US granted patents filed between 2015 and 2025, spanning 95 technology areas.
What is UTI Inc.'s Innovation Score?
UTI Inc. has an Innovation Score of 63.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does UTI Inc. focus on?
UTI Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 30 patents. The company has filed patents in 95 CPC subclasses total.
Is UTI Inc.'s patent filing rate increasing or decreasing?
UTI Inc.'s recent filing velocity is +148% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for UTI Inc.'s patents?
UTI Inc.'s patents average 17.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the UTI Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
UTI's 115 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - UTI ranks #3,269 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.